Angela Choi

4.9k total citations · 1 hit paper
23 papers, 1.0k citations indexed

About

Angela Choi is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Angela Choi has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Angela Choi's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (12 papers) and Immune Cell Function and Interaction (7 papers). Angela Choi is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (12 papers) and Immune Cell Function and Interaction (7 papers). Angela Choi collaborates with scholars based in United States, Belgium and Austria. Angela Choi's co-authors include Peter Palese, Florian Krammer, Raffael Nachbagauer, Adolfo Garcı́a-Sastre, Ariana Hirsh, Randy A. Albrecht, Manon Cox, Ruvim Izikson, Madhusudan Rajendran and Michael Schotsaert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and Journal of Virology.

In The Last Decade

Angela Choi

22 papers receiving 996 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

2025 18 citations Mieke Soens, Jintanat Ananworanich et al. Vaccine profile →

Peers

Countries citing papers authored by Angela Choi

Since Specialization

Citations

This map shows the geographic impact of Angela Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Choi more than expected).

Fields of papers citing papers by Angela Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Choi. The network helps show where Angela Choi may publish in the future.

Co-authorship network of co-authors of Angela Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Choi. A scholar is included among the top collaborators of Angela Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Choi. Angela Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults breakdown → 2025 ·Vaccine ·Mieke Soens, Jintanat Ananworanich, (unknown), Kathryn Jean Lucas, José F. Cardona, Lawrence Sher, (unknown), (unknown), Carole Henry, Angela Choi, Andrei Avanesov, Ren Chen, Evelyn Du, (unknown), Rituparna Das, Jacqueline M. Miller, Raffael Nachbagauer	18
2	Associations of Breast Cancer Method of Detection With Tumor Characteristics, Treatments, and Overall Survival: A Propensity-Score-Matched Analysis 2025 ·American Journal of Roentgenology ·(unknown), (unknown), Angela Choi, (unknown), (unknown), (unknown), (unknown), (unknown), Cindy Lee	0
3	Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial 2024 ·The Journal of Infectious Diseases ·Jintanat Ananworanich, Ivan T. Lee, (unknown), (unknown), (unknown), Andrei Avanesov, Daniel Stadlbauer, Angela Choi, (unknown), Shannon McGrath, Hsiao-Hsuan Kuo, Carole Henry, Ren Chen, Wenmei Huang, Raffael Nachbagauer, Robert Paris	23
4	Protocol for establishing primary human lung organoid-derived air-liquid interface cultures from cryopreserved human lung tissue 2023 ·STAR Protocols ·(unknown), Sonia Jangra, Marina Yurieva, Jan Martínek, (unknown), (unknown), Angela Choi, Juan García-Bernalt Diego, Te-Chia Wu, Florentina Marches, Damien Chaussabel, Adolfo Garcı́a-Sastre, Michael Schotsaert, Adam Williams, Karolina Palucka	6
5	Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia 2023 ·Frontiers in Immunology ·Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, Prajakta Warang, (unknown), Sonia Jangra, Yong Chen, Bruno G. De Geest, Michael Schotsaert	8
6	RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine 2022 ·Frontiers in Immunology ·Sonia Jangra, (unknown), Angela Choi, Raveen Rathnasinghe, Yong Chen, Soner Yildiz, Lynda Coughlan, Adolfo Garcı́a-Sastre, Bruno G. De Geest, Michael Schotsaert	10
7	TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming 2021 ·Nature Immunology ·Gaëtan Barbet, (unknown), Michael Schotsaert, Stephen T. Yeung, Julien Moretti, (unknown), Giorgi Metreveli, Thomas J. Gardner, Angela Choi, Domenico Tortorella, Robert Tampé, Kamal M. Khanna, Adolfo Garcı́a-Sastre, J. Magarian Blander	32
8	A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro 2020 ·Scientific Reports ·Mohammad Amin Behzadi, Angela Choi, James Duehr, (unknown), Chitra Upadhyay, Michael Schotsaert, Peter Palese, Raffael Nachbagauer	8
9	Host immune response–inspired development of the influenza vaccine 2020 ·Annals of Allergy Asthma & Immunology ·Angela Choi, Adolfo Garcı́a-Sastre, Michael Schotsaert	10
10	A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy 2020 ·International Journal of Gynecological Cancer ·Emma Allanson, Yang Peng, Angela Choi, Sandra C. Hayes, Monika Janda, Andreas Obermair	25
11	Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses 2020 ·Frontiers in Immunology ·Angela Choi, Lorena Itatí Ibañez, Shirin Strohmeier, Florian Krammer, Adolfo Garcı́a-Sastre, Michael Schotsaert	9
12	Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice 2019 ·ImmunoHorizons ·Angela Choi, (unknown), (unknown), Daniel Stadlbauer, Arvind Rajabhathor, (unknown), (unknown), Marie Van der Wielen, Peter Palese, Adolfo Garcı́a-Sastre, Bruce L. Innis, Florian Krammer, Michael Schotsaert, Corey P. Mallett, Raffael Nachbagauer	35
13	Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts 2019 ·npj Vaccines ·Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad Amin Behzadi, Damien Friel, Arvind Rajabhathor, Angela Choi, Randy A. Albrecht, Muriel Debois, Adolfo Garcı́a-Sastre, (unknown), Weina Sun, Peter Palese, Corey P. Mallett, Bruce L. Innis, Florian Krammer, Carine Claeys	18
14	TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection 2019 ·Vaccines ·Angela Choi, (unknown), Xavier Saelens, Adolfo Garcı́a-Sastre, Michael Schotsaert	6
15	Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins 2017 ·Nature Immunology ·Raffael Nachbagauer, Angela Choi, Ariana Hirsh, Irina Margine, (unknown), Aldo Barrera, Marcela Ferrés, Randy A. Albrecht, Adolfo Garcı́a-Sastre, Nicole M. Bouvier, Kimihito Ito, Rafael Medina, Peter Palese, Florian Krammer	128
16	Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model 2017 ·mBio ·Henning Jacobsen, Madhusudan Rajendran, Angela Choi, Haakon Sjursen, Karl A. Brokstad, Rebecca Jane Cox, Peter Palese, Florian Krammer, Raffael Nachbagauer	61
17	A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies 2017 ·npj Vaccines ·Raffael Nachbagauer, Wen‐Chun Liu, Angela Choi, Teddy John Wohlbold, (unknown), Madhusudan Rajendran, Alicia Solórzano, (unknown), Adolfo Garcı́a-Sastre, Peter Palese, Randy A. Albrecht, Florian Krammer	113
18	Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection 2016 ·Cell Host & Microbe ·Carole J. Henry Dunand, Paul E. Leon, Min Huang, Angela Choi, Veronika Chromikova, (unknown), Gene S. Tan, John Cruz, Ariana Hirsh, Nai‐Ying Zheng, Caitlin E. Mullarkey, Francis A. Ennis, Masanori Terajima, John J. Treanor, David J. Topham, Kanta Subbarao, Peter Palese, Florian Krammer, Patrick C. Wilson	209
19	A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice 2016 ·npj Vaccines ·Raffael Nachbagauer, (unknown), Angela Choi, Ariana Hirsh, Édith Beaulieu, Nicolas Lecrenier, Bruce L. Innis, Peter Palese, Corey P. Mallett, Florian Krammer	77
20	Strategies to improve compliance among oral contraceptive pill users: a review of the literature 2014 ·SHILAP Revista de lepidopterología ·(unknown), Angela Choi	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact